129 results on '"Zeng, Qing-Lei"'
Search Results
2. Functional cure induced by tenofovir alafenamide plus peginterferon-alpha-2b in young children with chronic hepatitis B: a case series study
3. Correction to: Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study
4. LiverRisk score: An accurate, cost-effective tool to predict fibrosis, liver-related, and diabetes-related mortality in the general population
5. Development of a machine learning-based model to predict hepatic inflammation in chronic hepatitis B patients with concurrent hepatic steatosis: a cohort study
6. Machine Learning–Based Models for Advanced Fibrosis and Cirrhosis Diagnosis in Chronic Hepatitis B Patients With Hepatic Steatosis
7. ABC: a novel algorithm to stratify decompensation risk in patients with compensated advanced chronic liver disease (CHESS2108): an international, multicenter cohort study
8. Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study
9. Tenofovir Alafenamide for Pregnant Chinese Women With Active Chronic Hepatitis B: A Multicenter Prospective Study
10. Activation-induced pyroptosis contributes to the loss of MAIT cells in chronic HIV-1 infected patients
11. Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study
12. The development of hepatocarcinoma after long-term antivirus treatment of Chinese patients with chronic hepatitis B virus infection: Incidence, long-term outcomes and predictive factors
13. TOP-078 - Pyroptotic MAITs link microbial translocation with severity of alcohol-related liver disease
14. Interferon-α plus ribavirin yields 98 % sustained virologic response in children aged 1–5 years with iatrogenic chronic hepatitis C
15. TOP-006 Development and validation of a home-based score to detect advanced liver fibrosis and long-term liver-related outcomes in the general population: a multicohort study
16. WED-272 A self-testing index for detecting hepatic steatosis and prognostication in the general population
17. AMPK activation ameliorates D-GalN/LPS-induced acute liver failure by upregulating Foxo3A to induce autophagy
18. HCV-specific interleukin-21+CD4+ T cells responses associated with viral control through the modulation of HCV-specific CD8+ T cells function in chronic hepatitis C patients
19. Sofosbuvir‐based therapy for late pregnant women and infants with severe chronic hepatitis C: A case series study.
20. Interleukin-21 mediates hepatitis B virus-associated liver cirrhosis by activating hepatic stellate cells
21. Interferon-α plus ribavirin therapy yields 98% sustained virologic response in children aged 1-5 years with unsafe injection-acquired chronic hepatitis C: 47
22. Clinical Characteristics of Omicron SARS-CoV-2 Variant Infection After Non-mRNA-Based Vaccination in China.
23. Computed Tomography Images of Spontaneous Portosystemic Shunt in Liver Cirrhosis.
24. The Epidemiological, Clinical Features and Outcomes of Imported Chinese COVID-19 Patients Following Inactivated Vaccines Injection.
25. WED-122 - Eight weeks or less of tenofovir alafenamide to prevent the perinatal hepatitis B transmission: a multicenter, prospective, randomized study
26. SAT-510 - Establishment and validation of a diagnostic model for liver inflammation in chronic hepatitis B (CHB) patients concurrent with non-alcoholic fatty liver disease (NAFLD) based on machine learning (ML)
27. SAT-463 - A diagnostic non-invasive model for liver advanced fibrosis and cirrhosis in chronic hepatitis B (CHB) concurrent with non-alcoholic fatty liver disease (NAFLD) based on machine learning (ML)
28. THU-471 - Diabetes mellitus (DM) is the strongest risk factor of significant inflammation or fibrosis in chronic hepatitis B (CHB) combined with non-alcoholic fatty liver disease (NAFLD)
29. Frequency of circulating CD4+CXCR5+TFH cells are associated with disease severity and treatment outcome in primary biliary cirrhosis patients: 2048
30. Protective role of Vδ2 γδT cells in patients with chronic hepatitis B through regulating function of Th17 cells: 1853
31. Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective, Observational Study.
32. Genomic Epidemiology of SARS-CoV-2 From Mainland China With Newly Obtained Genomes From Henan Province.
33. Ionic liquid extraction of silkworm pupa protein and its biological characteristics.
34. Clinical course and treatment efficacy of COVID‐19 near Hubei Province, China: A multicentre, retrospective study.
35. Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019.
36. Short-term Peginterferon-Induced High Functional Cure Rate in Inactive Chronic Hepatitis B Virus Carriers With Low Surface Antigen Levels.
37. p65/miR‐23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma.
38. IL‐17A‐mediated ERK1/2/p65 signaling pathway is associated with cell apoptosis after non‐alcoholic steatohepatitis.
39. MiR-19a Affects Hepatocyte Autophagy via Regulating lncRNA NBR2 and AMPK/PPARα in D-GalN/Lipopolysaccharide-Stimulated Hepatocytes.
40. Generic ledipasvir-sofosbuvir for patients with chronic hepatitis C: A real-life observational study.
41. Reply letter regarding seroconversion of hepatitis B surface antigen in a successful long-term immune cohort.
42. Requirement for further validation on the seroconversion of hepatitis B surface antigen in successful vaccinees.
43. Upregulation of OX40 ligand on monocytes contributes to early virological control in patients with chronic hepatitis C.
44. Age versus clinical virological characteristics in chronic hepatitis B virus infection: a case series study in China.
45. Response to Malkovsky.
46. Reply to Rabelo-da-Ponte et al.
47. Unexpected high incidence of hepatocellular carcinoma in patients with hepatitis C in the era of DAAs: Too alarming?
48. Prevalence of Hepatitis C Virus and Hepatitis B Virus Infections in Patients Infected with HIV Through Blood Donation or Transfusion in China.
49. “Fatty” or “steatotic”: position statement from a linguistic perspective by the Chinese-speaking community
50. Curing of chronic hepatitis C combined with coronavirus disease 2019 in a couple over 85 years old: a case series study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.